Clinical Trial Update: Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of sublingual flumazenil (CRLS035) in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Flumazenil (flumazenil)

Snippet

Sponsor: Coeruleus Ltd. | Conditions: Insomnia | Phase 1 | Status: COMPLETED